Inclisiran Sodium, sold under the brand name Leqvio, is a medication for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH). Reference standards of Inclisiran Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Inclisiran Sodium
Catalogue No.:PA 09 1400000
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....